We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Receives an exclusive license from Harvard University to integrate pioneering bioreactor technology that accommodates model ventricles and optional valves into the "human heart-in-a-jar" model
Leveraging extensive sales and marketing experience, as well as a multitude of long-standing connections and relationships in the pharmaceutical industry and biotechnology sector